PulmCCM

PulmCCM

Share this post

PulmCCM
PulmCCM
Amikacin for Ventilator-Associated Pneumonia (AMIKINHAL trial)

Amikacin for Ventilator-Associated Pneumonia (AMIKINHAL trial)

PulmCCM's avatar
PulmCCM
Oct 08, 2023
∙ Paid
2

Share this post

PulmCCM
PulmCCM
Amikacin for Ventilator-Associated Pneumonia (AMIKINHAL trial)
Share

You don’t hear much about ventilator-associated pneumonia (VAP) anymore. It used to be highly prevalent in U.S. ICUs, and a popular research focus for academics, generating a steady stream of papers. Then, in 2009, the condition disappeared completely.

Just kidding! In 2008, the U.S. government proposed adding VAP to its “hospital-acquired conditions” li…

Keep reading with a 7-day free trial

Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 PulmCCM LLC
Publisher Terms
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share